Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

Thymosin β4 helps heal wounds, grow hair, and improve blood vessel formation.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Tcf3 helps cells move and heal wounds by controlling lipocalin 2.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Berberine delivery systems improve wound healing by enhancing bioavailability, reducing inflammation, and promoting tissue regeneration.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

HB24 helps convert IBA to IAA, promoting root hair growth.

Prenatal diagnosis of trichothiodystrophy is possible in the second trimester using fetal eyebrow biopsy, with sulfur content analysis being more reliable.

TGF-β receptor 1 helps deer antlers grow by aiding skin and cartilage cell growth.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Testosterone injections can cause skin darkening and thickening.

Terminalia bellirica extracts effectively promote hair regrowth and treat androgenetic alopecia.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

The Itpr3 gene causes a specific hair pattern in mice.

Tridax procumbens may be a safe, affordable treatment for some health issues.

Longer treatment with vismodegib lowers relapse risk in basal cell carcinoma.

Pexidartinib often causes liver issues and fatigue, especially in women.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

These new skin treatments are safer and more effective with minimal side effects.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.